Zdrowie i gospodarka · 21/12/1999

FDA Releases Draft Guidance on Labeling for Over-the-Counter Sample Collection Systems for Drugs of Abuse Testing

The FDA has made available a draft guidance document outlining labeling recommendations for over-the-counter sample collection systems used for drug abuse testing, following the proposed reclassification of these devices as Class I restricted devices.